mRNA |
VX-680 |
CTRPv2 |
pan-cancer |
AAC |
0.37 |
0.0004 |
mRNA |
Talazoparib |
GDSC1000 |
pan-cancer |
AAC |
0.12 |
0.0004 |
mRNA |
Curcumin |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.0005 |
mRNA |
Gemcitabine |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.0006 |
mRNA |
Topotecan |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.0008 |
mRNA |
alisertib |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.0008 |
mRNA |
RG-108 |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
0.0008 |
mRNA |
etoposide |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.001 |
mRNA |
decitabine:carboplatin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.001 |
mRNA |
doxorubicin:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.001 |